The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
-
Int. J. Tuberc. Lung Dis. · Mar 2013
Randomized Controlled Trial Comparative StudyRifampicin plus isoniazid for the prevention of tuberculosis in an immigrant population.
To compare the tolerance, adherence and effectiveness of two approaches for the treatment of latent tuberculosis infection (LTBI): 6 months of isoniazid (6H) vs. 3 months of isoniazid plus rifampicin (3RH). ⋯ The 3RH regimen facilitates adherence to LTBI treatment and offers a safe, well-tolerated and effective alternative.